C oronary artery disease (CAD) is a leading cause of death and disability in developed countries. 1 In patients with known or suspected CAD, stress single-photon emission computed tomography (SPECT) and stress echocardiography account for the vast majority of tests currently performed for ischemia detection. The diagnostic role of these 2 imaging modalities is well established, and a negative stress test with either SPECT or echocardiography is able to identify subjects at low risk of future cardiovascular events. 2, 3 However, the use of stress SPECT may be hampered by soft-tissue attenuation artifacts and may expose patients to ionizing radiations, whereas disadvantages of stress echocardiography include suboptimal acoustic window in ≤25% of patients and frequent signal dropout in the anterior and lateral left ventricular walls. 2 Cardiac magnetic resonance (CMR) has recently undergone significant evolution in terms of imaging capabilities and feasibility. 4 It now represents a valuable alternative to other noninvasive imaging techniques with the possibility of overcoming some of their limitations in the evaluation of patients with CAD. The detection of myocardial ischemia with stress CMR is typically based on first-pass perfusion imaging, with the acquisition of high-spatial-resolution images during the injection of a bolus of a gadolinium-based contrast agent to search for inducible perfusion defects (PDs), or on wall motion abnormality (WMA) imaging, based on iterative collection of cine images allowing the identification of inducible impairment of regional systolic function. Previous reports on stress CMR showed good diagnostic accuracy for the detection of significant CAD. 5 Very recently, a few prospective studies and a meta-analysis reported higher diagnostic accuracy of stress CMR when compared with myocardial SPECT for the diagnosis of CAD. [6] [7] [8] However, the prognostic value of CMR has only been evaluated in single-center studies of relatively limited sample size. Thus, we performed a meta-analysis of published studies, including patients with known or suspected CAD, to assess the predictive value for adverse cardiac ischemic events of normal stress CMR, defined as the absence of inducible PDs and the absence of inducible WMAs.
Methods

Data Sources and Study Selection
An English literature search was performed using the PubMed and Cochrane databases to identify articles published between January 1985 and April 2012. The search for studies was restricted to data obtained in humans and adults and was conducted using the following key words (alone and in different combinations): prognosis, prognostic value, stress, dipyridamole, adenosine, dobutamine, and CMR. The title and abstract of potentially relevant studies were screened for appropriateness before retrieval of the full article when relevant. Additional studies were identified by contacting authors working in the field and searching cited references of relevant articles. A study was included if all of the following criteria were met: (1) the study had prospective or retrospective analysis of subjects referred for suspected or known CAD who underwent pharmacological stress CMR for searching inducible ischemia; (2) the study included a negative test defined in the absence of inducible PDs and the absence of inducible WMAs during stress CMR; (3) the study provided the absolute number of patients with a negative test and primary data on clinical outcomes of nonfatal myocardial infarction (MI) and cardiac death; and (4) the follow-up time of the study was ≥3 months. Because only preliminary studies have been performed to evaluate the feasibility of exercise CMR, we excluded articles that used exercise as a stressor. In case of multiple studies reported from the same research group, potential cohort duplication was avoided by including the largest study only. Overall study quality was not used as a prespecified inclusion criterion. 9
Data Extraction and Quality Assessment
To evaluate eligibility for the meta-analysis, as previously described, [10] [11] [12] each study was initially identified by considering journal, author, and year of publication. Additional extracted variables included study design (retrospective or prospective), MRI system, CMR sequence used for image acquisition, criterion used to classify a test as negative, type of pharmacological stressor used (dipyridamole, adenosine, or dobutamine), orientation and number of the obtained slices, and modality of data assessment (qualitative, semiquantitative, or quantitative). Data were also collected on age and on prevalence of female sex, traditional cardiovastily history of CAD, smoking), angina-like symptoms, history of CAD (including previous MI and previous myocardial revascularization), and prevalence of patients with late gadolinium enhancement (LGE) as detected by CMR. Mean and median follow-up time, number of events, or event rate based on negative tests, occurrence of primary outcomes (nonfatal MI or cardiac death), and secondary outcomes (coronary revascularization and admission for unstable angina [UA]) were recorded.
Quality assessment was performed using a previously described methodology 13 and was on the basis of the presence of the following parameters: (1) complete follow-up in the majority of subjects (≥90% of the baseline cohort); (2) outcome data collected by investigators blinded to the test results; and (3) outcomes corroborated by hospital records and death certificates. Studies were defined as good quality if they fulfilled criterion 1 and ≥1 of the other 2 criteria, as fair quality if they fulfilled only the criterion 1, and as poor quality if they fulfilled none of the criteria.
Statistical Analysis
Demographical and clinical characteristics of all patients included in this meta-analysis were obtained as weighted averages of those reported in the single studies, the weights being the total sample size for each study. Statistical heterogeneity between studies was assessed using the Cochrane Q statistic (with a value of P<0.1 reflecting significant heterogeneity) and I 2 statistic, 14, 15 which measures the percentage of total variability across studies not due to sampling error. Because of the large heterogeneity experienced, the pooled estimates of negative predictive value (NPV) for both hard and soft events and the pooled estimates of the event rate after negative tests (ERNT=1−NPV) were computed using the random-effects model of DerSimonian and Laird. 16 To correct for overdispersion, the raw proportions (NPV and ERNT) were initially converted using the Freeman-Tukey transformation and backtransformed after quantitative data synthesis. 17, 18 For each study, the annualized ERNT was obtained as average during the lengths of follow-up. To investigate the potential sources of heterogeneity, subgroup analysis was a priori planned for the following categorical variables: criterion to define the test as negative (studies that considered the absence of PDs versus studies considering the absence of WMAs) and quality of studies (good versus fair). Univariate random-effects meta-regression analyses were used to examine the effects of other continuous variables.
Publication bias was visually checked by funnel plot and formally assessed using the Egger test. 19 All analyses were performed with R statistics (version 2.15.0), using the additional packages META e METAFOR.
Results
The initial database search identified 556 potentially eligible citations. After application of filters for human, English language, and adults (age >19 years), 202 studies were selected. Two couples of investigators (P.G. and S.D.; G.S. and E.B.) reviewed the titles and abstracts of these studies, discharging 171 citations because they were judged to be nonrelevant/nonpertinent. To determine eligibility, each couple of investigators reviewed the full text of the remaining 31 independently, and disagreements were resolved by the senior author (P.P.-F.). After revision, 18 articles were excluded. Thirteen articles were finally enrolled; in 1 of the studies, 20 a negative test was defined in case of coexisting absence of inducible PDs and WMAs, so each of the parameters was separately considered, and the study was included twice in all analyses. Accordingly, the final analysis considered 14 studies 20-32 including 12 178 patients. The complete literature search is presented in flow-chart form in Figure I in the online-only Data Supplement.
Demographical and clinical characteristics of patients included in the studies in the meta-analysis are detailed in Table 1 . Study sample sizes ranged from 203 to 1722 patients enrolled, including a variable proportion of patients with previous CAD (0%-64%). The mean patient age ranged from 57 to 65 years, with the proportion of July 2013 women ranging from 16% to 100%. The duration of followup after CMR ranged from 12 to 74 months; the primary ERNT (nonfatal MI and cardiac death) varied between 0% and 9.32%; and the primary annualized ERNT varied between 0% and 3.92%.
After quality assessment, 7 studies were graded as good quality 24,25,27-29,31,32 and 7 studies as fair quality. [20] [21] [22] [23] 26, 30 Of the 13 series of patients included for subanalysis using the criterion to define the test as negative, 7 used the absence of inducible PDs [20] [21] [22] 27, [29] [30] [31] as the criterion to define a negative test; of these studies, 1 used dipyridamole as the stressor, 4 used adenosine, and 2 used a stress protocol with both dipyridamole and adenosine. In the remaining 6 series of patients, the definition of a negative study was based on the absence of inducible Table 1 Author Bingham et al 21 Bodi et al 20 Bodi et al 20 Coelho-Filho et al 22 Gebker et al 23 Hundley et al 24 Year WMAs 20,23-25,27,32 ; of these, 1 used dipyridamole and 5 used dobutamine as the stressor. Data from 1 study were not considered for subanalysis because information related to PDs and WMAs could not be separated. 26 In this study, dobutamine was used as the stressor. Eight of the 14 included studies reported rates of myocardial revascularization and UA in addition to major coronary events. Figure 1 shows the forest plot of NPV and ERNT for nonfatal MI and cardiac death for each study, as well as the pooled estimates yielded by the random-effect model. In the individual studies, NPV ranged from 90.68% to 100%. During a weighted mean follow-up of 25.3 months, the summary NPV 25 Korosoglou et al 26 Krittayaphong et al 27 Kuijpers et al 28 Lo et al 29 Pilz et al 30 Steel et al 31 A high level of heterogeneity was observed between studies (I 2 =83.1%; P<0.0001), and in univariate random-effects meta-regression analysis, it showed a significant association with the prevalence of patients with previous coronary artery bypass graft and percutaneous coronary intervention (β=−0.09%; 95% CI, −0.14 to −0.04; P=0.001) and the prevalence of LGE (β=−0.06%; 95% CI, −0.09 to −0.02; P=0.001; Table 2 ).
. Demographical and Clinical Characteristics of Patients Included in the Studies Enrolled in Meta-analysis
Predictive Value of Stress CMR for Cardiac Death and Nonfatal MI
Comparable NPVs for the prediction of major coronary events during follow-up were obtained in studies considering the absence of inducible PDs to define a negative test compared with those evaluating the absence of inducible WMAs (98.39% versus 97.31%, respectively; P=0.263 by meta-regression analysis). However, the level of heterogeneity was higher in the group of studies evaluating WMAs (I 2 =84.3%) compared with studies assessing PDs (I 2 =67.9%; Figure 2 ).
In subgroup analysis by study quality, fair-quality studies resulted in a higher pooled NPV compared with that observed in high-quality studies (98.85% versus 96.89%, respectively; P=0.031 by meta-regression analysis), although the annualized ERNT was similar between them (1.05% versus 1.03%). The heterogeneity remained high in both good quality (I 2 =79.7%) and fair-quality (I 2 =80.1%; Figure 3 ) studies.
Predictive Value of Stress CMR for Myocardial Revascularization and UA
Rates of coronary revascularization and admission for UA were provided in 8 of the 14 series of patients. 20, [26] [27] [28] [29] [30] Figure 4 shows the forest plot of the NPV and ERNT for each study, as well as the pooled estimates yielded by the random-effect model (I 2 =94.7%; P<0.001). The individual NPVs ranged from 75.27% to 100%. The summary NPV, during a weighted mean follow-up of 20.4 months, was equal to 97.17% (95% CI, 94.70-98.91), resulting in a pooled ERNT of 2.83% (95% CI, 1.09-5.30). The corresponding annualized ERNT in patients with a negative test was 1.73%. Because of the small number of studies reporting information on secondary events, neither subgroup analysis nor meta-regression was conducted.
Publication Bias
There was no evidence of significant publication bias for studies enrolled in this meta-analysis using the Egger test 19 (α=-2.21, P=0.219 for cardiac death and nonfatal MI; α=-3.99, P=0.341 for myocardial revascularization and UA). These findings were consistent with the funnel plots shown in Figures 2 and 3 in the online-only Data Supplement, respectively.
Discussion
Although the diagnostic accuracy of stress CMR has been repeatedly reported in single studies and in meta-analyses, [5] [6] [7] the prognostic value of stress CMR for predicting major adverse cardiac events is less defined. This systematic review and meta-analysis are the first comprehensive analysis of available literature reporting the prognostic value of cardiac stress MRI in subjects with known or suspected CAD. Our analysis revealed that in subjects evaluated for known or suspected CAD, the absence of inducible ischemia on stress CMR predicts a low risk of cardiovascular events during a short-term to midterm follow-up. The calculated annualized major event rate after a normal stress CMR was ≈1%; this is only slightly higher than the background event rate observed in healthy low-risk individuals (<1%). 33 In a previous meta-analysis considering stress SPECT and stress echocardiography for noninvasive risk stratification, very low (<1%) annualized event rates have been reported in subjects with a normal imaging stress test. 3 However, this analysis considered only studies using physical exercise stress, which may have introduced a bias toward a relatively more healthy population. In fact, subjects undergoing pharmacological stress tests generally have a worse prognosis. 34 A different meta-analysis, comparing risk stratification with pharmacological and exercise stress SPECT in patients with known or suspected CAD, reported that annualized ERNT (for cardiac death and nonfatal MI) after normal pharmacological SPECT was significantly higher than after normal exercise SPECT (1.78% versus 0.65%; P<0.001), and at meta-regression analysis, exercise capacity was the single most important predictor of cardiac events. 35 Stress CMR is almost exclusively performed with pharmacological stress because standard equipment for exercise is generally not compatible with MRI, CMR image acquisition may be difficult under postexercise conditions for high heart rate and rapid breathing, and ECG signal is adversely affected by the system used for CMR imaging. However, exercise stress may offer information about functional capacity, blood pressure, and heart rate response to physical activity, arrhythmias, and the link between symptom reproducibility and the presence of ischemia. 36 Recently, Raman et al, 37 using a modified treadmill constructed to be located in the scanner room, studied with exercise stress CMR 43 patients undergoing exercise stress SPECT because of known or suspected CAD. Agreement between SPECT and CMR was moderate (κ=0.58) without significant difference in CAD diagnosis (P=0.625). Interestingly, at the 6-month follow-up, cardiac death and nonfatal MI did not occur in any of the 29 patients with normal exercise CMR (NPV=100%) and in 33 of 34 patients with normal exercise SPECT (NPV=99%). Unfortunately, exercise CMR might not have been easy to implement, especially outside research centers, because of the requirement for expensive dedicated exercise equipment and difficulties in obtaining adequate images owing to technical limitations such as frequent occurrence of motion artifacts.
With stress CMR, both myocardial perfusion and systolic function can be accurately assessed. Our results highlighted that the NPV of stress CMR in predicting adverse events is similar for studies considering PDs and those based on the evaluation of WMAs to define a negative examination. Because the occurrence of PDs precedes the development of WMAs on the basis of ischemic cascade, perfusion CMR could be more sensitive in ischemia detection, although the induction of WMAs at CMR should be associated with more severe ischemic burden. Actually, the assessment of myocardial PDs and WMAs during a single stress session with stress CMR appeared to enhance the sensitivity for ischemia detection. 38 In a large cohort of patients, Korosoglou et al 26 showed a very low risk of major cardiac events (0.4%) after negative CMR with concurrent evaluation of PDs and WMAs, suggesting that myocardial wall motion and perfusion assessment could yield complementary prognostic information.
Evaluation of LGE in the left ventricular myocardium to detect previous myocardial necrosis is part of standard CMR protocols applied to the characterization of patients with CAD. A growing body of evidence is pointing to the prognostic value of LGE in several clinical scenarios and suggests the potential for combining this information with that provided by myocardial perfusion and wall motion assessment during a stress CMR study. 39, 40 In this regard, using CMR, Steel et al 31 reported the lowest annual event rates (<2%) for cardiac death or nonfatal MI in the group of patients with neither reversible PDs nor LGE. More recently, Bingham et al 21 found a very low annual cardiac mortality rate (≤0.4%) in patients contemporaneously showing normal perfusion, no LGE, normal aortic flow, and left ventricular function evaluated at CMR, emphasizing the great potential of this modality for assessing within a single examination complementary prognostic parameters. Our results are consistent with this previous evidence of an additional value of LGE for prognostic stratification, as demonstrated by the observed interaction of the prevalence of patients with LGE and the capacity of CMR-detected ischemia to predict the risk of hard cardiac events.
In our meta-analysis, we did not include analyses of positive predictive values. These values are particularly subject to bias because of differing patient risk profiles, as well as to the effect of positive tests on subsequent revascularization and medical management. Variation in test performance among subjects at very high or very low risk of disease (spectrum bias) may also affect the results of prognostic studies and the assessment of NPV. 41 Our systematic review includes studies of cohorts with supposedly varying pretest risk of disease, as manifested by a broad range of percentages of subjects with major cardiovascular risk factor, history of CAD, prior MI, history of previous coronary revascularization procedures, or anginal symptoms ( Table 1 ). The assessment of pretest risk is relevant for evaluating the clinical impact of cardiovascular imaging, 42 but the availability of incomplete clinical data in many of the included studies prevents the possibility of performing further subgroup analyses and consequently evaluating more carefully the NPV in relation to pretest risk. However, meta-regression analysis showed that the percentage of patients with previous revascularization (coronary artery bypass graft and percutaneous coronary intervention) was a significant predictor of major cardiac events, increasing the risk of cardiac death/nonfatal MI after normal CMR. In addition, our meta-analysis excluded patients at the highest risk of cardiac events such as those hospitalized for acute chest pain syndrome 43 or with recent MI. 44 Thus, even though our study showed a low annualized event rate associated with the absence of inducible ischemia at stress CMR, it should be cautioned that the negative predictive power of the test might be lower in patient populations at very high cardiovascular risk.
Limitations
As previously reported for other meta-analyses reporting the diagnostic and prognostic value of noninvasive imaging modalities in patients with CAD, our results were obtained from a relatively limited number of studies with a moderate to high level of heterogeneity. In addition, not all studies provided data on risk factors, presence of symptoms, prevalence of known CAD, and previous revascularization procedures; therefore, we could not perform additional subgroup analyses. Compared with more traditional imaging modalities, stress CMR reached a less advanced level of standardization on the applied methodology for both image acquisition and interpretation, including the number and orientation of acquired slices, rate and concentration of contrast infusion, and methods for image interpretation. These aspects may have represented additional sources of heterogeneity among studies included in this meta-analysis.
Furthermore, we know that double-counting of the study of Bodi et al 20 in the main analysis might be debatable from a methodological standpoint because of potential incorrect increase of population. The authors reported a separate analysis for wall motion and perfusion in the same patients. Therefore, we treated these 2 analyses as 2 different studies. Although this allowed us to add wall motion and perfusion results to the respective subgroup analyses in our study, it slightly increased the true number of patients collected in the main analysis. However, the consistency of the results of this study with the results of other included studies makes a substantial impact on the main findings of the analysis unlikely.
Conclusions
Stress CMR provides a high NPV for adverse cardiac events in subjects with known or suspected CAD. The ability to identify low-risk subjects with stress CMR does not differ whether the absence of inducible PDs or the absence of inducible WMAs is used to define a negative test.
Combining perfusion and wall motion assessment with LGE may further increase the prognostic power of stress CMR and deserves further evaluation in prospective clinical trials.
